Customized Logistics Services
With over 140,000 square feet dedicated to laboratory operations, Medpace Central Laboratories has complete control of the preparation, packaging, and delivery of all supplies and materials necessary for sample collection and shipment. Our flexible system ensures rapid preparation and distribution of reliable study and site-specific kits following stringent quality checks. Medpace has industry leading timelines for distributing first collection supplies to clinical sites within 5-7 weeks of receiving the final protocol.
Our intelligent supply chain management system is customized to your specific needs and provide full lot and expiry date tracking for production and on-time distribution of customized sample collection kits. Medpace Laboratories provides suitable packaging materials for ambient, refrigerated, and frozen specimens. Shipping is managed through preferred relationships with leading couriers in industry based upon their documented performance in specific geographic areas. Investigator sites will receive a customized study folder with detailed sample collection, handling and shipping instructions, concise and easy-to-use quick reference charts, and preprinted requisition forms.
All materials, including selected and prepared packaging and sample collection products, and all shipping procedures are compliant with International Air Transport Association (IATA) regulations.
ClinTrak Remote Data Access link to ClinTrak Lab
ClinTrak Lab® provides a 24/7/365 web tool for quick visibility of global data for Sponsors, and site specific data for investigative sites. ClinTrak Lab® provides customizable, study-specific, user-defined flagging and reporting options as well as study monitoring tools (including graphing capabilities) and secure, web-based reporting. This provides near real-time access to study progress monitoring with cumulative and trending reports.
Resources
Brochure: Medpace Labs
Fact Sheet: Central Laboratories
Friedewald Formula Significantly Underestimates LDL Cholesterol Compared to Preparative Ultracentrifugation below 70 mg/dL leading to Overestimation of the LDL Cholesterol Reduction for New drugs in Development
Accurate Assessment of LDL Cholesterol Reduction at Levels Below 70mg/dL Has Implications in the Estimation of Efficacy for New Drugs in Development
Underestimation of LDL Cholesterol Below 70 mg/dL (1.8 mmol/L) by Friedewald, Hopkins and a “Direct” Assay Compared to Preparative Ultracentrifugation Leading to the Overestimation of LDL Cholesterol Reduction for New Drugs in Development
